Clinical Trial Update: Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on interval cytoreductive surgery with or without HIPEC for ovarian cancer (FOCUS / KOV-HIPEC-04), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Ovarian Cancer | Phase 3 | Status: RECRUITING